4.7 Article

Comparison of the Abbott m2000 RealTime CT Assay and the Cepheid GeneXpert CT/NG Assay to the Roche Amplicor CT Assay for Detection of Chlamydia trachomatis in Ocular Samples from Tanzania

Journal

JOURNAL OF CLINICAL MICROBIOLOGY
Volume 51, Issue 5, Pages 1611-1613

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.00519-13

Keywords

-

Categories

Funding

  1. Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)
  2. Bill and Melinda Gates Foundation
  3. Abbott Molecular Diagnostics
  4. BD Diagnostics
  5. Beckman Coulter
  6. Cepheid
  7. Roche Molecular Diagnostics
  8. Gen-Probe Hologic

Ask authors/readers for more resources

The GeneXpert CT/NG assay (GeneXpert) and the Abbott m2000 RealTime CT (m2000) assay were compared to Amplicor for detecting ocular Chlamydia trachomatis. Discordant specimens were tested by the Aptima CT assay. The m2000 assay sensitivity was 100% (95% confidence interval [CI], 90% to 100%), and specificity was 98.46% (95% CI, 95.2% to 99.2%); GeneXpert sensitivity was 100% (95% CI, 90% to 100%), and specificity was 100% (95% CI, 98.1% to 100%). The m2000 and GeneXpert assays appear to perform as well as the Amplicor assay.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available